|

BGB-58067 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Nader Sanai1
  • BeOne Medicines1

Indications

  • Cancer2
  • Glioblastoma (GBM)1
  • Advanced Solid Tumor1

Phoenix, Arizona1 trial

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

St. Joseph's Hospital and Medical Center

Early 1

Los Angeles, California1 trial

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Usc Norris Comprehensive Cancer Center (Nccc)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.